Real-time enrollment status for this severe asthma clinical trial
Current Status
Active, Not Recruiting
Checked: July 18, 2026 at 12:24 PM UTC
| NCT Number | NCT05692180 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Severe Asthma |
| Phase | PHASE3 |
| Target Enrollment | 200 participants |
| Active Locations | 28 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 17, 2026 (Yesterday) |
As of July 18, 2026: Clinical trial NCT05692180 is currently active_not_recruiting participants. This phase3 study for severe asthma is not currently accepting new participants at 28 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05692180 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05692180 was last updated Yesterday (July 17, 2026). HelloStudys verifies this status automatically.